Company / Debt per Share
BioLife Solutions, Inc. Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.10
FY2025
5-year range
$0.10 / $0.59
FY2021-FY2025
Trend
-70.3%
vs FY2024
Sector context
#98 of 100
Health Care
What the data says
Among 100 Health Care companies, BioLife Solutions, Inc. is in the top 2% for debt per share. Debt per Share has declined for 3 consecutive years, from $0.59 in FY2022 to $0.10 in FY2025.
Based on SEC 10-K filings.
0.10 in FY2025 with a 5-year CAGR of +17.2%.
Improved from $0.55 to $0.10 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -44.3%
- 5-Year CAGR
- +17.2%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 100This company $0.10 Sector average $45.62
▼
-99.8% below sector average
Key checks
Key Insights
- BioLife Solutions, Inc.'s debt per share has declined for 3 consecutive years.
- In FY2025, debt per share decreased 70.3% year-over-year.
- Ranks #98 out of 100 companies in the Health Care sector.
- Peak debt per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | -70.3% |
| FY2024 | $0.35 | -36.6% |
| FY2023 | $0.55 | -8.3% |
| FY2022 | $0.59 | +217.3% |
| FY2021 | $0.19 | +303.2% |
| FY2020 | $0.05 | +6856.7% |
| FY2019 | $0.00 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $0.34 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026